Fortress Biotech, Inc.
FBIONasdaqCIK 1429260HealthcareFiscal year ends Dec 31
Reports and events: 358 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0116:30 ET | 8-K | 8.01 Other events | 0001104659-26-112845 |
| 2026-08-1316:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-095964 |
| 2026-08-1316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095931 |
| 2026-06-2316:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-076811 |
| 2026-05-1416:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-061233 |
| 2026-05-1416:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-061208 |
| 2026-04-2816:15 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001104659-26-050358 |
| 2026-03-3117:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-037874 |
| 2026-03-3116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-037749 |
| 2026-03-3017:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-036818 |
| 2026-03-2016:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-032728 |
| 2026-02-2308:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-018371 |
| 2026-01-1309:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-003121 |
| 2026-01-0616:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-001305 |
| 2026-01-0517:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-000690 |
| 2025-12-1617:53 ET | S-1 | Registration statement | 0001104659-25-121266 |
| 2025-12-1516:33 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001104659-25-121187 |
| 2025-12-1508:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120893 |
| 2025-11-1707:30 ET | 8-K | 8.01 Other events | 0001104659-25-112945 |
| 2025-11-1408:46 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-111989 |
| 2025-11-1408:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-111979 |
| 2025-10-0116:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-095631 |
| 2025-10-0108:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-095366 |
| 2025-08-1416:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011570 |
| 2025-08-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011561 |
| 2025-07-1617:25 ET | 8-K | 8.01 Other events | 0001558370-25-009264 |
| 2025-06-2308:55 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-008787 |
| 2025-06-0516:15 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001558370-25-008433 |
| 2025-06-0318:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-056072 |
| 2025-05-1516:34 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007898 |
| 2025-05-1516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007878 |
| 2025-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001558370-25-005678 |
| 2025-04-1616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-004898 |
| 2025-04-0217:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-031261 |
| 2025-04-0217:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-031241 |
| 2025-03-3116:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004160 |
| 2025-03-3116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-004154 |
| 2025-03-1116:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-022575 |
| 2025-03-1008:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-25-002541 |
| 2025-01-1616:20 ET | 8-K | 8.01 Other events | 0001558370-25-000247 |
| 2025-01-0608:05 ET | 8-K | 8.01 Other events | 0001558370-25-000025 |
| 2025-01-0318:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-000921 |
| 2025-01-0318:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-000920 |
| 2025-01-0317:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-000898 |
| 2024-12-1616:50 ET | 8-K | 8.01 Other events | 0001558370-24-016294 |
| 2024-11-1516:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-119704 |
| 2024-11-1416:40 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015740 |
| 2024-11-1416:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015726 |
| 2024-11-0409:11 ET | 8-K | 8.01 Other events | 0001558370-24-014186 |
| 2024-10-0116:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-104932 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.